Tranilast was effective in hamster models of cardiomyopathy and myocyte degeneration by resulting in the effective removal of TRPV2 from the sarcolemma of DCM hamsters [4, 5, 9]. The gene discussed is TRPV2; the disease is cardiomyopathy.